Striatal Transplantation in a Transgenic Mouse Model of Huntington's Disease

By Dunnett S.B.   Carter R.J.   Watts C.   Torres E.M.   Mahal A.   Mangiarini L.   Bates G.   Morton A.J.  

Experimental Neurology, Vol. 154, Iss. 1, 1998-11 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

Huntington's Disease Intranuclear Inclusions Contain Truncated, Ubiquitinated Huntingtin Protein

By Sieradzan K.A.   Mechan A.O.   Jones L.   Wanker E.E.   Nukina N.   Mann D.M.A.  

Experimental Neurology, Vol. 156, Iss. 1, 1999-03 ,pp. : 92-99

Elsevier

Access to resources Recommend Favorite

Loss of normal huntingtin function: new developments in Huntington's disease research

By Cattaneo E.   Rigamonti D.   Goffredo D.   Zuccato C.   Squitieri F.   Sipione S.  

Trends in Neurosciences, Vol. 24, Iss. 3, 2001-03 ,pp. : 182-188

Elsevier

Access to resources Recommend Favorite

Maintenance of Susceptibility to Neurodegeneration Following Intrastriatal Injections of Quinolinic Acid in a New Transgenic Mouse Model of Huntington's Disease

By Petersen A.   Chase K.   Puschban Z.   DiFiglia M.   Brundin P.   Aronin N.  

Experimental Neurology, Vol. 175, Iss. 1, 2002-05 ,pp. : 297-300

Elsevier

Access to resources Recommend Favorite

Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington’s disease

By Johann Verena   Schiefer Johannes   Sass Christian   Mey Jörg   Brook Gary   Krüttgen Alexander   Schlangen Christiane   Bernreuther Christian   Schachner Melitta   Dihné Marcel   Kosinski Christoph  

Experimental Brain Research, Vol. 177, Iss. 4, 2007-03 ,pp. : 458-470

Springer Publishing Company

Access to resources Recommend Favorite